BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2260878)

  • 1. [Inhibitory effects of CPT-11 on liver metastases in nude mice injected with human pancreatic tumor cells into their spleens].
    Takeda S; Kono A
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2433-6. PubMed ID: 2260878
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitumor effect of DX-8951, a novel camptothecin analog, on human pancreatic tumor cells and their CPT-11-resistant variants cultured in vitro and xenografted into nude mice.
    Takiguchi S; Kumazawa E; Shimazoe T; Tohgo A; Kono A
    Jpn J Cancer Res; 1997 Aug; 88(8):760-9. PubMed ID: 9330608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antitumor effect of camptothecin analog on liver metastatic model of human colon cancer in nude mice].
    Takiguchi S; Shimazoe T; Kono A
    Gan To Kagaku Ryoho; 1994 Apr; 21(5):705-8. PubMed ID: 8154898
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages.
    Bruns CJ; Shinohara H; Harbison MT; Davis DW; Nelkin G; Killion JJ; McConkey DJ; Dong Z; Fidler IJ
    Cancer Res; 2000 Jan; 60(1):2-7. PubMed ID: 10646841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition of human cancer metastases by camptothecins in newly developed xenograft models.
    Potmesil M; Vardeman D; Kozielski AJ; Mendoza J; Stehlin JS; Giovanella BC
    Cancer Res; 1995 Dec; 55(23):5637-41. PubMed ID: 7585647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha potentiates the antiproliferative activity of CPT-11 against human colon cancer xenografts in nude mice.
    Kobayashi I; Ohwada S; Maemura M
    Anticancer Res; 1996; 16(5A):2677-80. PubMed ID: 8917369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel cytotoxic 7-iminomethyl and 7-aminomethyl derivatives of camptothecin.
    Dallavalle S; Ferrari A; Merlini L; Penco S; Carenini N; De Cesare M; Perego P; Pratesi G; Zunino F
    Bioorg Med Chem Lett; 2001 Feb; 11(3):291-4. PubMed ID: 11212094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A late phase II study of CPT-11, irinotecan hydrochloride, in patients with advanced pancreatic cancer. CPT-11 Study Group on Gastrointestinal Cancer].
    Sakata Y; Shimada Y; Yoshino M; Kambe M; Futatsuki K; Nakao I; Ogawa N; Wakui A; Taguchi T
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1039-46. PubMed ID: 8210255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of a rabbit liver carboxylesterase sensitizes human tumor cells to CPT-11.
    Danks MK; Morton CL; Pawlik CA; Potter PM
    Cancer Res; 1998 Jan; 58(1):20-2. PubMed ID: 9426050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytotoxic effect of CPT-11 against human recurrent carcinoma cells primarily cultured on contact-sensitive plates: preliminary report].
    Matsuoka H; Abe R; Ueo H; Akiyoshi T; Furusawa M; Yamamoto M; Sugimachi K
    Nihon Geka Gakkai Zasshi; 1992 Nov; 93(11):1451. PubMed ID: 1448053
    [No Abstract]   [Full Text] [Related]  

  • 11. Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts.
    Pratesi G; De Cesare M; Carenini N; Perego P; Righetti SC; Cucco C; Merlini L; Pisano C; Penco S; Carminati P; Vesci L; Zunino F
    Clin Cancer Res; 2002 Dec; 8(12):3904-9. PubMed ID: 12473606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Water soluble 20(S)-glycinate esters of 10,11-methylenedioxycamptothecins are highly active against human breast cancer xenografts.
    Wadkins RM; Potter PM; Vladu B; Marty J; Mangold G; Weitman S; Manikumar G; Wani MC; Wall ME; Von Hoff DD
    Cancer Res; 1999 Jul; 59(14):3424-8. PubMed ID: 10416605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of administration schedules on the antitumor activity of CPT-11, a camptothecin derivative].
    Furuta T; Yokokura T
    Gan To Kagaku Ryoho; 1990 Jan; 17(1):121-30. PubMed ID: 2297233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental study on intraperitoneal versus intravenous CPT-11 for peritoneal seeding and liver metastasis].
    Maruyama M; Nagahama T; Ebuchi M; Yuasa Y
    Gan To Kagaku Ryoho; 2000 Oct; 27(12):1855-7. PubMed ID: 11086429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effect of irinotecan hydrochloride (CPT-11) on human renal tumors heterotransplanted in nude mice.
    Miki T; Nonomura N; Takaha N; Nishimura K; Kojima Y; Sawada M; Okuyama A
    Int J Urol; 1998 Jul; 5(4):370-3. PubMed ID: 9712447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraperitoneal versus intravenous CPT-11 for peritoneal seeding and liver metastasis.
    Maruyama M; Nagahama T; Yuasa Y
    Anticancer Res; 1999; 19(5B):4187-91. PubMed ID: 10628373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of an orthotopic model of pancreatic cancer to evaluate the antitumor effects of irinotecan through the biomarker carbohydrate antigen 19-9 in mice.
    Li L; Yue GG; Fung KP; Leung PC; Lau CB; Leung PS
    Pancreas; 2014 Oct; 43(7):1126-8. PubMed ID: 25207664
    [No Abstract]   [Full Text] [Related]  

  • 18. Camptothecin delivery systems: enhanced efficacy and tumor accumulation of camptothecin following its conjugation to polyethylene glycol via a glycine linker.
    Conover CD; Greenwald RB; Pendri A; Gilbert CW; Shum KL
    Cancer Chemother Pharmacol; 1998; 42(5):407-14. PubMed ID: 9771956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibition of human gastrointestinal cancer xenograft lines by treatment with CPT-11 and VP-16.
    Nagai S; Yamauchi M; Satta T; Kodera Y; Kondou K; Akiyaya S; Ito K; Takagi H
    J Surg Oncol; 1993 Dec; 54(4):211-5. PubMed ID: 8255079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: lack of cross-resistance in vivo in tumors with acquired resistance to the topoisomerase I inhibitor 9-dimethylaminomethyl-10-hydroxycamptothecin.
    Houghton PJ; Cheshire PJ; Hallman JC; Bissery MC; Mathieu-Boué A; Houghton JA
    Cancer Res; 1993 Jun; 53(12):2823-9. PubMed ID: 8504425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.